Profound Medical Corp (TSX:PRN)

C$ 10.23 0.03 (0.3%) Market Cap: 301.19 Mil Enterprise Value: 271.15 Mil PE Ratio: 0 PB Ratio: 5.88 GF Score: 68/100

Q3 2024 Profound Medical Corp Earnings Call Transcript
Nov 07, 2024

C$12.35 (+10.27%)

Earnings
Q2 2024 Profound Medical Corp Earnings Call Transcript
Aug 08, 2024

C$12.89 (-3.37%)

Earnings
Q3 2023 Profound Medical Corp Earnings Call Transcript
Nov 02, 2023

C$12.3 (+7.89%)

Earnings
Profound Medical Corp at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023
Q2 2023 Profound Medical Corp Earnings Call Transcript
Aug 09, 2023

C$13.72 (-4.79%)

Earnings
Profound Medical Corp at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Q1 2023 Profound Medical Corp Earnings Call Transcript
May 10, 2023

C$17.52 (-0.17%)

Earnings
Profound Medical Corp at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 26, 2023
Profound Medical Corp at Cowen Health Care Conference Transcript
Mar 08, 2023
Q4 2022 Profound Medical Corp Earnings Call Transcript
Mar 07, 2023

C$15.79 (-2.71%)

Earnings
Profound Medical Corp at Jefferies London Healthcare Conference Transcript
Nov 15, 2022
Q3 2022 Profound Medical Corp Earnings Call Transcript
Nov 03, 2022

C$5.38 (+5.70%)

Earnings
Q2 2022 Profound Medical Corp Earnings Call Transcript
Aug 04, 2022

C$11.99 (+1.01%)

Earnings
Profound Medical Corp Annual Shareholders Meeting Transcript
May 18, 2022
Q1 2022 Profound Medical Corp Earnings Call Transcript
May 09, 2022

C$8.7 (-5.13%)

Earnings
Profound Medical Corp at Bloom Burton & Co. Healthcare Investor Conference Transcript
May 02, 2022
Q4 2021 Profound Medical Corp Earnings Call Transcript
Mar 03, 2022

C$11.9 (-5.85%)

Earnings
Q3 2021 Profound Medical Corp Earnings Call Transcript
Nov 04, 2021

C$16.85 (+2.62%)

Earnings
Q2 2021 Profound Medical Corp Earnings Call Transcript
Aug 04, 2021

C$16.79 (-6.25%)

Earnings
Profound Medical Corp at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Profound Medical Corp Annual Shareholders Meeting Transcript
May 19, 2021
Q1 2021 Profound Medical Corp Earnings Call Transcript
May 12, 2021

C$21.76 (-4.73%)

Earnings
Profound Medical Corp at Cowen Healthcare Conference (Virtual) Transcript
Mar 04, 2021
Q4 2020 Profound Medical Corp Earnings Call Transcript
Mar 02, 2021

C$28.34 (-2.11%)

Earnings
Q3 2020 Profound Medical Corp Earnings Call Transcript
Nov 05, 2020

C$23.54 (-1.01%)

Earnings
Q2 2020 Profound Medical Corp Earnings Call Transcript
Aug 06, 2020

C$20.07 (-4.29%)

Earnings
Profound Medical Corp Annual Shareholders Meeting Transcript
May 20, 2020
Q1 2020 Profound Medical Corp Earnings Call Transcript
May 07, 2020

C$18.29 (+0.83%)

Earnings
Q4 2019 Profound Medical Corp Earnings Call Transcript
Mar 03, 2020

C$17.46 (-2.62%)

Earnings
Q3 2019 Profound Medical Corp Earnings Call Transcript
Nov 07, 2019

C$12.43 (-1.43%)

Earnings

Profound Medical Corp at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:30PM GMT

Release Date Price: C$19.67 (+3.91%)

Transcript

Mike Sarcone

Jefferies - Analyst

All right. Thank you. I think we can start. My name is Mike Sarcone. I am an analyst on the medical supplies and devices team here at Jefferies.

For this session, we've got Profound Medical and from the company, we've got Arun Menawat, CEO and Rashed Dewan, CFO. Arun is going to kick it off with a presentation. And if we have some time at the end, we can open it up for Q&A. So gentlemen, thanks for joining us today and Arun, I'll pass it to you.

Arun Menawat

Profound Medical Corp. - CEO & Chairman of the Board

Thank you so much, Michael. I'm really delighted to be here. And I'm delighted to be talking about Profound. So our mission is really to move surgery from minimally invasive or robotic surgeries to the next level, which we think is in incision-free surgery. So, big task.

And ablation of prostate tissue is our first of those applications. And I'm going to talk exclusively about prostate disease. So it's the largest cancer among men after skin cancer. There are two treatments that are really the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.